These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15341595

  • 1. An evolutionarily conserved mechanism for sensitization of soluble guanylyl cyclase reveals extensive nitric oxide-mediated upregulation of cyclic GMP in insect brain.
    Ott SR, Delago A, Elphick MR.
    Eur J Neurosci; 2004 Sep; 20(5):1231-44. PubMed ID: 15341595
    [Abstract] [Full Text] [Related]

  • 2. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL, Hung HW, Kao SH, Teng CM, Wu CC, Cheng SJ.
    Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
    [Abstract] [Full Text] [Related]

  • 3. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]

  • 4. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

  • 5. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J, Zabel U, Hübner U, Hatzelmann A, Wagner B, Wanner C, Schmidt HH.
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [Abstract] [Full Text] [Related]

  • 6. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE, Priviero FB, Webb RC.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [Abstract] [Full Text] [Related]

  • 7. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A, Müllershausen F, Smolenski A, Walter U, Schultz G, Koesling D.
    Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
    [Abstract] [Full Text] [Related]

  • 8. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS.
    Biomed Khim; 2007 Dec; 53(4):385-99. PubMed ID: 18035720
    [Abstract] [Full Text] [Related]

  • 9. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P, Malinski T, Ruetten H, Schindler U, Linz W, Schoenafinger K, Strobel H, Wiemer G.
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [Abstract] [Full Text] [Related]

  • 10. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S, Sips P, Buys E, Brouckaert P, Van de Voorde J.
    Cardiovasc Res; 2007 Oct 01; 76(1):149-59. PubMed ID: 17610859
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC, Garthwaite J.
    Br J Pharmacol; 2002 May 01; 136(1):95-103. PubMed ID: 11976273
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272.
    Mullershausen F, Russwurm M, Friebe A, Koesling D.
    Circulation; 2004 Apr 13; 109(14):1711-3. PubMed ID: 15066950
    [Abstract] [Full Text] [Related]

  • 13. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.
    Nakane M, Hsieh G, Miller LN, Chang R, Terranova MA, Moreland RB, Kolasa T, Brioni JD.
    Int J Impot Res; 2002 Apr 13; 14(2):121-7. PubMed ID: 11979328
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
    Schmidt K, Schrammel A, Koesling D, Mayer B.
    Mol Pharmacol; 2001 Feb 13; 59(2):220-4. PubMed ID: 11160856
    [Abstract] [Full Text] [Related]

  • 15. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
    Lamothe M, Chang FJ, Balashova N, Shirokov R, Beuve A.
    Biochemistry; 2004 Mar 23; 43(11):3039-48. PubMed ID: 15023055
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide/cyclic guanosine monophosphate signaling in the central complex of the grasshopper brain inhibits singing behavior.
    Wenzel B, Kunst M, Günther C, Ganter GK, Lakes-Harlan R, Elsner N, Heinrich R.
    J Comp Neurol; 2005 Jul 25; 488(2):129-39. PubMed ID: 15924338
    [Abstract] [Full Text] [Related]

  • 17. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB, Hobbs AJ, MacAllister RJ.
    Br J Pharmacol; 1999 Nov 25; 128(5):1082-8. PubMed ID: 10556946
    [Abstract] [Full Text] [Related]

  • 18. Localization and characterization of cGMP-immunoreactive structures in rat brain slices after NO-dependent and NO-independent stimulation of soluble guanylyl cyclase.
    van Staveren WC, Markerink-van Ittersum M, Steinbusch HW, Behrends S, de Vente J.
    Brain Res; 2005 Mar 02; 1036(1-2):77-89. PubMed ID: 15725404
    [Abstract] [Full Text] [Related]

  • 19. Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
    Dismuke WM, Sharif NA, Ellis DZ.
    Invest Ophthalmol Vis Sci; 2009 Jul 02; 50(7):3353-9. PubMed ID: 19234350
    [Abstract] [Full Text] [Related]

  • 20. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
    Martin E, Lee YC, Murad F.
    Proc Natl Acad Sci U S A; 2001 Nov 06; 98(23):12938-42. PubMed ID: 11687640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.